Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse
Introduction and hypothesis The objective was to investigate the long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse. Methods This was a retrospective study of patients who underwent Le Fort colpocleisis from January 2007 to August 20...
Gespeichert in:
Veröffentlicht in: | INTERNATIONAL UROGYNECOLOGY JOURNAL 2021-04, Vol.32 (4), p.879-884 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 884 |
---|---|
container_issue | 4 |
container_start_page | 879 |
container_title | INTERNATIONAL UROGYNECOLOGY JOURNAL |
container_volume | 32 |
creator | Wang, Yi-ting Zhang, Kun Wang, Hui-fang Yang, Jun-fang Ying, Yao Han, Jin-song |
description | Introduction and hypothesis
The objective was to investigate the long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse.
Methods
This was a retrospective study of patients who underwent Le Fort colpocleisis from January 2007 to August 2018 in our hospital. Follow-up was conducted via outpatient visits or the telephone. Records were reviewed for anatomical recurrence, complications, urinary and intestinal symptoms post-operation, reoperation rate, patient satisfaction, Patient Global Impression of Improvement (PGI-I) score, regret rate etc.
Results
A total of 208 patients underwent follow-up. The follow-up time was 60.7 ± 34.18 (12–140) months. There were no intraoperative complications. Postoperative urinary retention occurred in 3.8% of patients (8 out of 208). There was no anatomical recurrence. New or more severe urinary symptoms occurred in 8.7% of patients (18 out of 208); new or more severe intestinal symptoms occurred in 1.9% of patients (4 out of 208). The reoperation rate was 1.44% (3 out of 208). Three cases of reoperation occurred for the following reasons: a case of severe stress urinary incontinence, a case of abscess in the vaginal septum, and a case of uterine malignancy after 2 years of colpocleisis. Patient satisfaction was as follows: 98.6% (205 out of 208) of patients were very satisfied. The PGI-I score was very much improved or improved in 99.5% (207 out of 208) of patients. A total of 0.96% (2 out of 208) of patients regretted undergoing colpocleisis.
Conclusions
The long-term follow-up results showed that Le Fort colpocleisis was a safe and effective surgical procedure associated with high satisfaction. There was a very low regret rate, but the procedure should be taken seriously. |
doi_str_mv | 10.1007/s00192-020-04380-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32601781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2419098929</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-fae2037b9b68bb30ac400063543bea45863c3a825712bc30410e3e89650afefd3</originalsourceid><addsrcrecordid>eNqNkUGL1TAQx4Mo7nP1C3iQgBdBqpNMmrZHebgqPPCi55DmTZ5d2qYm6cp-e_PsuoIH8TQ5_P6Tmfkx9lzAGwHQvE0AopMVSKhAYQtV-4DthEKsECQ-ZDvosKlQaXnBnqR0DQAKanjMLlBqEE0rdmw9hPlUZYoTJ-8HZ90tt_ORLzYPNGeeSk3eujyEmQfPD8SvQszchXEJbqQhDYn7EHn-RjxHsnk6xwqZ6IYi8YXGm8HxEE925ksMo10SPWWPvB0TPburl-zr1fsv-4_V4fOHT_t3h8phU-fKW5KATd_1uu17BOtU2UFjrbAnq-pWo0PbyroRsncISgAhtZ2uwXryR7xkr7a-5ePvK6VspiE5Gkc7U1iTkUp00LWd7Ar68i_0OqxxLtMZWYPulNL6TMmNcjGkFMmbJQ6TjbdGgDlLMZsUU6SYX1JMW0Iv7lqv_UTH-8hvCwVoN-AH9cEnVy7v6B4rK9dKCa2wvEDsh2zPNvZhnXOJvv7_aKFxo1Mh5hPFP0v-Y_6f9Ve4Lg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506944669</pqid></control><display><type>article</type><title>Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse</title><source>SpringerNature Journals</source><creator>Wang, Yi-ting ; Zhang, Kun ; Wang, Hui-fang ; Yang, Jun-fang ; Ying, Yao ; Han, Jin-song</creator><creatorcontrib>Wang, Yi-ting ; Zhang, Kun ; Wang, Hui-fang ; Yang, Jun-fang ; Ying, Yao ; Han, Jin-song</creatorcontrib><description>Introduction and hypothesis
The objective was to investigate the long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse.
Methods
This was a retrospective study of patients who underwent Le Fort colpocleisis from January 2007 to August 2018 in our hospital. Follow-up was conducted via outpatient visits or the telephone. Records were reviewed for anatomical recurrence, complications, urinary and intestinal symptoms post-operation, reoperation rate, patient satisfaction, Patient Global Impression of Improvement (PGI-I) score, regret rate etc.
Results
A total of 208 patients underwent follow-up. The follow-up time was 60.7 ± 34.18 (12–140) months. There were no intraoperative complications. Postoperative urinary retention occurred in 3.8% of patients (8 out of 208). There was no anatomical recurrence. New or more severe urinary symptoms occurred in 8.7% of patients (18 out of 208); new or more severe intestinal symptoms occurred in 1.9% of patients (4 out of 208). The reoperation rate was 1.44% (3 out of 208). Three cases of reoperation occurred for the following reasons: a case of severe stress urinary incontinence, a case of abscess in the vaginal septum, and a case of uterine malignancy after 2 years of colpocleisis. Patient satisfaction was as follows: 98.6% (205 out of 208) of patients were very satisfied. The PGI-I score was very much improved or improved in 99.5% (207 out of 208) of patients. A total of 0.96% (2 out of 208) of patients regretted undergoing colpocleisis.
Conclusions
The long-term follow-up results showed that Le Fort colpocleisis was a safe and effective surgical procedure associated with high satisfaction. There was a very low regret rate, but the procedure should be taken seriously.</description><identifier>ISSN: 0937-3462</identifier><identifier>EISSN: 1433-3023</identifier><identifier>DOI: 10.1007/s00192-020-04380-8</identifier><identifier>PMID: 32601781</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abscesses ; Catheters ; Comorbidity ; Gynecology ; Hysterectomy ; Life Sciences & Biomedicine ; Medicine ; Medicine & Public Health ; Obstetrics & Gynecology ; Older people ; Original Article ; Patient satisfaction ; Pelvic organ prolapse ; Science & Technology ; Surgery ; Surgical outcomes ; Urinary incontinence ; Urinary retention ; Urology ; Urology & Nephrology ; Uterine cancer ; Uterus ; Vagina</subject><ispartof>INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021-04, Vol.32 (4), p.879-884</ispartof><rights>The International Urogynecological Association 2020</rights><rights>The International Urogynecological Association 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>3</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000544164300001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c375t-fae2037b9b68bb30ac400063543bea45863c3a825712bc30410e3e89650afefd3</citedby><cites>FETCH-LOGICAL-c375t-fae2037b9b68bb30ac400063543bea45863c3a825712bc30410e3e89650afefd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00192-020-04380-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00192-020-04380-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27928,27929,41492,42561,51323</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32601781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yi-ting</creatorcontrib><creatorcontrib>Zhang, Kun</creatorcontrib><creatorcontrib>Wang, Hui-fang</creatorcontrib><creatorcontrib>Yang, Jun-fang</creatorcontrib><creatorcontrib>Ying, Yao</creatorcontrib><creatorcontrib>Han, Jin-song</creatorcontrib><title>Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse</title><title>INTERNATIONAL UROGYNECOLOGY JOURNAL</title><addtitle>Int Urogynecol J</addtitle><addtitle>INT UROGYNECOL J</addtitle><addtitle>Int Urogynecol J</addtitle><description>Introduction and hypothesis
The objective was to investigate the long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse.
Methods
This was a retrospective study of patients who underwent Le Fort colpocleisis from January 2007 to August 2018 in our hospital. Follow-up was conducted via outpatient visits or the telephone. Records were reviewed for anatomical recurrence, complications, urinary and intestinal symptoms post-operation, reoperation rate, patient satisfaction, Patient Global Impression of Improvement (PGI-I) score, regret rate etc.
Results
A total of 208 patients underwent follow-up. The follow-up time was 60.7 ± 34.18 (12–140) months. There were no intraoperative complications. Postoperative urinary retention occurred in 3.8% of patients (8 out of 208). There was no anatomical recurrence. New or more severe urinary symptoms occurred in 8.7% of patients (18 out of 208); new or more severe intestinal symptoms occurred in 1.9% of patients (4 out of 208). The reoperation rate was 1.44% (3 out of 208). Three cases of reoperation occurred for the following reasons: a case of severe stress urinary incontinence, a case of abscess in the vaginal septum, and a case of uterine malignancy after 2 years of colpocleisis. Patient satisfaction was as follows: 98.6% (205 out of 208) of patients were very satisfied. The PGI-I score was very much improved or improved in 99.5% (207 out of 208) of patients. A total of 0.96% (2 out of 208) of patients regretted undergoing colpocleisis.
Conclusions
The long-term follow-up results showed that Le Fort colpocleisis was a safe and effective surgical procedure associated with high satisfaction. There was a very low regret rate, but the procedure should be taken seriously.</description><subject>Abscesses</subject><subject>Catheters</subject><subject>Comorbidity</subject><subject>Gynecology</subject><subject>Hysterectomy</subject><subject>Life Sciences & Biomedicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Obstetrics & Gynecology</subject><subject>Older people</subject><subject>Original Article</subject><subject>Patient satisfaction</subject><subject>Pelvic organ prolapse</subject><subject>Science & Technology</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Urinary incontinence</subject><subject>Urinary retention</subject><subject>Urology</subject><subject>Urology & Nephrology</subject><subject>Uterine cancer</subject><subject>Uterus</subject><subject>Vagina</subject><issn>0937-3462</issn><issn>1433-3023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkUGL1TAQx4Mo7nP1C3iQgBdBqpNMmrZHebgqPPCi55DmTZ5d2qYm6cp-e_PsuoIH8TQ5_P6Tmfkx9lzAGwHQvE0AopMVSKhAYQtV-4DthEKsECQ-ZDvosKlQaXnBnqR0DQAKanjMLlBqEE0rdmw9hPlUZYoTJ-8HZ90tt_ORLzYPNGeeSk3eujyEmQfPD8SvQszchXEJbqQhDYn7EHn-RjxHsnk6xwqZ6IYi8YXGm8HxEE925ksMo10SPWWPvB0TPburl-zr1fsv-4_V4fOHT_t3h8phU-fKW5KATd_1uu17BOtU2UFjrbAnq-pWo0PbyroRsncISgAhtZ2uwXryR7xkr7a-5ePvK6VspiE5Gkc7U1iTkUp00LWd7Ar68i_0OqxxLtMZWYPulNL6TMmNcjGkFMmbJQ6TjbdGgDlLMZsUU6SYX1JMW0Iv7lqv_UTH-8hvCwVoN-AH9cEnVy7v6B4rK9dKCa2wvEDsh2zPNvZhnXOJvv7_aKFxo1Mh5hPFP0v-Y_6f9Ve4Lg</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Wang, Yi-ting</creator><creator>Zhang, Kun</creator><creator>Wang, Hui-fang</creator><creator>Yang, Jun-fang</creator><creator>Ying, Yao</creator><creator>Han, Jin-song</creator><general>Springer International Publishing</general><general>Springer Nature</general><general>Springer Nature B.V</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20210401</creationdate><title>Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse</title><author>Wang, Yi-ting ; Zhang, Kun ; Wang, Hui-fang ; Yang, Jun-fang ; Ying, Yao ; Han, Jin-song</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-fae2037b9b68bb30ac400063543bea45863c3a825712bc30410e3e89650afefd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abscesses</topic><topic>Catheters</topic><topic>Comorbidity</topic><topic>Gynecology</topic><topic>Hysterectomy</topic><topic>Life Sciences & Biomedicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Obstetrics & Gynecology</topic><topic>Older people</topic><topic>Original Article</topic><topic>Patient satisfaction</topic><topic>Pelvic organ prolapse</topic><topic>Science & Technology</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Urinary incontinence</topic><topic>Urinary retention</topic><topic>Urology</topic><topic>Urology & Nephrology</topic><topic>Uterine cancer</topic><topic>Uterus</topic><topic>Vagina</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yi-ting</creatorcontrib><creatorcontrib>Zhang, Kun</creatorcontrib><creatorcontrib>Wang, Hui-fang</creatorcontrib><creatorcontrib>Yang, Jun-fang</creatorcontrib><creatorcontrib>Ying, Yao</creatorcontrib><creatorcontrib>Han, Jin-song</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Proquest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>INTERNATIONAL UROGYNECOLOGY JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yi-ting</au><au>Zhang, Kun</au><au>Wang, Hui-fang</au><au>Yang, Jun-fang</au><au>Ying, Yao</au><au>Han, Jin-song</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse</atitle><jtitle>INTERNATIONAL UROGYNECOLOGY JOURNAL</jtitle><stitle>Int Urogynecol J</stitle><stitle>INT UROGYNECOL J</stitle><addtitle>Int Urogynecol J</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>32</volume><issue>4</issue><spage>879</spage><epage>884</epage><pages>879-884</pages><issn>0937-3462</issn><eissn>1433-3023</eissn><abstract>Introduction and hypothesis
The objective was to investigate the long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse.
Methods
This was a retrospective study of patients who underwent Le Fort colpocleisis from January 2007 to August 2018 in our hospital. Follow-up was conducted via outpatient visits or the telephone. Records were reviewed for anatomical recurrence, complications, urinary and intestinal symptoms post-operation, reoperation rate, patient satisfaction, Patient Global Impression of Improvement (PGI-I) score, regret rate etc.
Results
A total of 208 patients underwent follow-up. The follow-up time was 60.7 ± 34.18 (12–140) months. There were no intraoperative complications. Postoperative urinary retention occurred in 3.8% of patients (8 out of 208). There was no anatomical recurrence. New or more severe urinary symptoms occurred in 8.7% of patients (18 out of 208); new or more severe intestinal symptoms occurred in 1.9% of patients (4 out of 208). The reoperation rate was 1.44% (3 out of 208). Three cases of reoperation occurred for the following reasons: a case of severe stress urinary incontinence, a case of abscess in the vaginal septum, and a case of uterine malignancy after 2 years of colpocleisis. Patient satisfaction was as follows: 98.6% (205 out of 208) of patients were very satisfied. The PGI-I score was very much improved or improved in 99.5% (207 out of 208) of patients. A total of 0.96% (2 out of 208) of patients regretted undergoing colpocleisis.
Conclusions
The long-term follow-up results showed that Le Fort colpocleisis was a safe and effective surgical procedure associated with high satisfaction. There was a very low regret rate, but the procedure should be taken seriously.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32601781</pmid><doi>10.1007/s00192-020-04380-8</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0937-3462 |
ispartof | INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021-04, Vol.32 (4), p.879-884 |
issn | 0937-3462 1433-3023 |
language | eng |
recordid | cdi_pubmed_primary_32601781 |
source | SpringerNature Journals |
subjects | Abscesses Catheters Comorbidity Gynecology Hysterectomy Life Sciences & Biomedicine Medicine Medicine & Public Health Obstetrics & Gynecology Older people Original Article Patient satisfaction Pelvic organ prolapse Science & Technology Surgery Surgical outcomes Urinary incontinence Urinary retention Urology Urology & Nephrology Uterine cancer Uterus Vagina |
title | Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T06%3A14%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20efficacy%20and%20patient%20satisfaction%20of%20Le%20Fort%20colpocleisis%20for%20the%20treatment%20of%20severe%20pelvic%20organ%20prolapse&rft.jtitle=INTERNATIONAL%20UROGYNECOLOGY%20JOURNAL&rft.au=Wang,%20Yi-ting&rft.date=2021-04-01&rft.volume=32&rft.issue=4&rft.spage=879&rft.epage=884&rft.pages=879-884&rft.issn=0937-3462&rft.eissn=1433-3023&rft_id=info:doi/10.1007/s00192-020-04380-8&rft_dat=%3Cproquest_pubme%3E2419098929%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2506944669&rft_id=info:pmid/32601781&rfr_iscdi=true |